Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Gains from Investment Securities (2022 - 2025)

SOPHiA GENETICS's Gains from Investment Securities history spans 4 years, with the latest figure at $5000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 103.09% to $5000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$200000.0, a 62.69% increase, with the full-year FY2025 number at -$200000.0, up 62.69% from a year prior.
  • Gains from Investment Securities hit $5000.0 in Q4 2025 for SOPHiA GENETICS, up from -$59000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for SOPH hit a ceiling of $704000.0 in Q3 2023 and a floor of -$555000.0 in Q2 2023.
  • Historically, Gains from Investment Securities has averaged -$54461.5 across 4 years, with a median of -$45000.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: soared 2111.43% in 2023 and later tumbled 4400.0% in 2025.
  • Tracing SOPH's Gains from Investment Securities over 4 years: stood at $35000.0 in 2022, then soared by 1911.43% to $704000.0 in 2023, then plummeted by 123.01% to -$162000.0 in 2024, then skyrocketed by 103.09% to $5000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SOPH at $5000.0 in Q4 2025, -$59000.0 in Q3 2025, and -$101000.0 in Q2 2025.